BI
ALBO

BVF Inc’s Albireo Pharma Inc ALBO Stock Holding History

BVF Inc’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-29,000
Closed -$580K – 63
2019
Q3 		$580K Sell
29,000
-36,500
-56% -$945K 0.06% 58
2019
Q2 		$2.11M Sell
65,500
-135,000
-67% -$4.52M 0.23% 52
2019
Q1 		$6.46M Hold
200,500
– – 0.72% 38
2018
Q4 		$4.92M Sell
200,500
-18,300
-8% -$484K 0.64% 40
2018
Q3 		$7.21M Sell
218,800
-1,200
-0.5% -$39.2K 0.63% 40
2018
Q2 		$7.81M Sell
220,000
-5,000
-2% -$162K 0.76% 35
2018
Q1 		$7.33M Buy
+225,000
New +$7.58M 0.74% 31

Other funds holding ALBO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BVF Inc's ALBO Position: Q4 2019 in Review

BVF Inc sold out of Albireo Pharma Inc (ALBO) in Q4 2019, closing a stake of 29,000 shares — an estimated $580K sold.

BVF Inc first reported a position in ALBO in Q1 2018 and held it in 7 quarters. The position peaked at $7.81M in Q2 2018. 70 funds tracked by Wall St. Rank hold ALBO as of Q4 2019.

  • BVF Inc reported no remaining Albireo Pharma Inc position as of Q4 2019 after selling out during the quarter.
  • BVF Inc sold 29,000 Albireo Pharma Inc shares in Q4 2019, an estimated $580K.
  • BVF Inc first reported a position in Albireo Pharma Inc in Q1 2018 and held it in 7 quarters.
  • BVF Inc's Albireo Pharma Inc position peaked at $7.81M in Q2 2018.
  • 70 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2019.

Based on BVF Inc's 13F filing for Q4 2019, filed 14 Feb 2020.